Guidance
SARS-CoV-2 lateral flow antigen tests: evaluation of VUI-202012/01
PHE Porton Down has carried out a rapid assessment on whether 5 lateral flow devices can detect the new COVID-19 variant.
Documents
Details
Working with academic collaborators at the University of Oxford, PHE Porton Down has been evaluating the performance of lateral flow devices (LFDs) since mid-August 2020. Over 60 have been considered to date, approximately 30% of which have progressed to extended evaluation on clinical samples at Phase 3.
Updates to this page
Published 23 December 2020